(Q42668610)

4 November 2017

title

Screening and early detection of lung cancer (English)

1 reference

4 November 2017

J Vansteenkiste

1

1 reference

4 November 2017

C Dooms

series ordinal

2

1 reference

4 November 2017

C Mascaux

series ordinal

3

1 reference

4 November 2017

K Nackaerts

series ordinal

4

1 reference

4 November 2017

publication date

1 September 2012

1 reference

4 November 2017

1 reference

4 November 2017

volume

23 Suppl 10

1 reference

4 November 2017

page(s)

x320-7

1 reference

Screening for lung cancer with chest radiographs

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Overview of observational studies of low-dose helical computed tomography screening for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Survival of patients with stage I lung cancer detected on CT screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Screening for lung cancer: is this the way forward?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Management of lung nodules detected by volume CT scanning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Nodule management protocol of the NELSON randomised lung cancer screening trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

21 January 2018

Overdiagnosis in cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Computed tomography screening for lung cancer without a smoking cessation program--not a cost-effective idea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Cost-effectiveness of computed tomography screening for lung cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Early detection and screening of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

A prediction model for lung cancer diagnosis that integrates genomic and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Technical validation of an autoantibody test for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Classification of lung cancer histology by gold nanoparticle sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

The value of autofluorescence bronchoscopy combined with white light bronchoscopy compared with white light alone in the diagnosis of intraepithelial neoplasia and invasive lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Synchronous roentgenographically occult lung carcinoma in patients with resectable primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Natural history of bronchial preinvasive lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Diagnostic bronchoscopy: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Surveillance for the detection of early lung cancer in patients with bronchial dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS303

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS303

1 reference

4 November 2017

1 reference